v3.24.1.u1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock
Limited common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive gain (loss)
Beginning balance (in shares) at Dec. 31, 2022   62,163,739 9,164,193      
Beginning balance at Dec. 31, 2022 $ 447,894 $ 622 $ 92 $ 828,700 $ (379,138) $ (2,382)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Change in unrealized gain (loss) on marketable securities 1,483         1,483
Issuances of common stock upon stock option exercises (in shares)   186,201        
Issuances of common stock upon stock option exercises 867 $ 1   866    
Issuance of common stock upon vesting of restricted stock units (in shares)   12,075        
Stock-based compensation 10,880     10,880    
Net (loss) income 129,136       129,136  
Ending balance (in shares) at Mar. 31, 2023   62,362,015 9,164,193      
Ending balance at Mar. 31, 2023 590,260 $ 623 $ 92 840,446 (250,002) (899)
Beginning balance (in shares) at Dec. 31, 2023   62,977,316 9,164,193      
Beginning balance at Dec. 31, 2023 548,558 $ 630 $ 92 885,973 (338,418) 281
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Change in unrealized gain (loss) on marketable securities (353)         (353)
Issuances of common stock upon stock option exercises (in shares)   41,623        
Issuances of common stock upon stock option exercises 390     390    
Issuance of common stock upon vesting of restricted stock units (in shares)   170,964        
Issuance of common stock upon vesting of RSUs (in shares) 2 $ 2        
Issuance of common stock upon ATM offering (in shares)   282,963        
Issuance of common stock in ATM offering 7,615 $ 3   7,612    
Stock-based compensation 12,218     12,218    
Net (loss) income (54,724)       (54,724)  
Ending balance (in shares) at Mar. 31, 2024   63,472,866 9,164,193      
Ending balance at Mar. 31, 2024 $ 513,706 $ 635 $ 92 $ 906,193 $ (393,142) $ (72)